DrugDev president, CEO Ibraheem Mahmood wins PM360 ELITE award
Ibraheem (Ibs) Mahmood, DrugDev president and CEO, has been voted among only six executives worldwide as a winner in the “Disrupter” category in its inaugural ELITE award program by PM360, a health-marketing industry trade magazine.
Over the past year Ibs was featured in a CenterWatch “Insider Insights” executive profile, named to the PharmaVOICE 100 most inspiring people in the life sciences industries and was a finalist for the SCRIP Executive of the Year award.
The ELITE awards by PM360 profile the most influential people in the healthcare industry. Nominees were evaluated based on their accomplishments, testimonials from clients and colleagues and supporting evidence that reflects the impact of their efforts. Winners were selected from among hundreds of nominations.
Other PM360 ELITE winners include Brenton “Brent” Saunders, the CEO of Actavis; Frank Segrave, president and CEO, Silvergate Pharmaceuticals; Hugh O’Neill, president, commercial operations, Mallinckrodt; and others.